fig3

Figure 3. Schematic representation of immunotherapy approaches to atherosclerosis. green indicates approaches currently used to treat atherosclerosis, blue indicates treatments for other diseases that have a positive effect on atherosclerosis, promising immunotherapy approaches that have demonstrated efficacy in preclinical studies are marked in orange, and approaches that have not demonstrated safe and effective action are marked in red.